STOCK TITAN

[SCHEDULE 13G/A] OptiNose, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A
Rhea-AI Filing Summary

OptiNose, Inc. filing discloses that Rosalind Advisors, Rosalind Master Fund L.P., Steven Salamon and Gilad Aharon report beneficial ownership of 0 common shares (0.0%) of OptiNose common stock. The filing lists no sole or shared voting power and no sole or shared dispositive power for any reporting person.

The statement identifies Rosalind Advisors as an adviser and Salamon and Aharon as portfolio managers and includes a certification that the securities are held in the ordinary course of business and were not acquired to influence control; ownership is reported as 5% or less.

OptiNose, Inc. ha comunicato che Rosalind Advisors, Rosalind Master Fund L.P., Steven Salamon e Gilad Aharon dichiarano una partecipazione beneficiaria pari a 0 azioni ordinarie (0,0%) del capitale ordinario di OptiNose. La comunicazione non indica poteri di voto né poteri dispositivi, né in forma esclusiva né condivisa, per alcuno dei soggetti segnalanti.

Il documento individua Rosalind Advisors come consulente e Salamon e Aharon come gestori di portafoglio e contiene la certificazione che i titoli sono detenuti nell'ambito dell'ordinaria attività di gestione e non sono stati acquisiti al fine di influenzare il controllo; la partecipazione è riportata come pari al 5% o inferiore.

OptiNose, Inc. informa que Rosalind Advisors, Rosalind Master Fund L.P., Steven Salamon y Gilad Aharon declaran una propiedad beneficiaria de 0 acciones ordinarias (0,0%) del capital social ordinario de OptiNose. El informe no registra poder de voto ni poder dispositivo, ni en forma exclusiva ni compartida, para ninguno de los informantes.

La declaración identifica a Rosalind Advisors como asesor y a Salamon y Aharon como gestores de cartera e incluye la certificación de que los valores se mantienen en el curso ordinario del negocio y no se adquirieron para influir en el control; la participación se informa como del 5% o menos.

OptiNose, Inc.의 제출서류에 따르면 Rosalind Advisors, Rosalind Master Fund L.P., Steven Salamon 및 Gilad Aharon이 OptiNose 보통주를 0주(0.0%) 보유한 것으로 보고했습니다. 제출서류에는 어떤 보고인에 대해서도 단독 또는 공동의 의결권이나 처분권이 기재되어 있지 않습니다.

진술서는 Rosalind Advisors를 자문사로, Salamon과 Aharon을 포트폴리오 매니저로 명시하며, 증권이 통상적인 영업 과정에서 보유되고 있고 지배권 행사 목적을 위해 취득된 것이 아니라는 인증을 포함하고 있습니다. 보유 비율은 5% 이하로 보고되었습니다.

OptiNose, Inc. indique que Rosalind Advisors, Rosalind Master Fund L.P., Steven Salamon et Gilad Aharon déclarent une participation bénéficiaire de 0 actions ordinaires (0,0 %) des actions ordinaires d'OptiNose. La déclaration ne mentionne aucun pouvoir de vote ni aucun pouvoir de disposition, ni en propre ni partagé, pour aucun des déclarants.

Le document identifie Rosalind Advisors comme conseiller et Salamon et Aharon comme gestionnaires de portefeuille et inclut la certification que les titres sont détenus dans le cours normal des affaires et n'ont pas été acquis pour influencer le contrôle ; la participation est indiquée comme égale ou inférieure à 5 %.

OptiNose, Inc. legt offen, dass Rosalind Advisors, Rosalind Master Fund L.P., Steven Salamon und Gilad Aharon eine wirtschaftliche Beteiligung von 0 Stammaktien (0,0 %) an den Stammaktien von OptiNose melden. In der Meldung werden weder alleiniges noch gemeinsames Stimmrecht noch alleiniges oder gemeinsames Verfügungsrecht für eine der meldepflichtigen Personen angegeben.

Die Erklärung nennt Rosalind Advisors als Berater und Salamon sowie Aharon als Portfoliomanager und enthält die Bestätigung, dass die Wertpapiere im normalen Geschäftsverlauf gehalten werden und nicht zum Zweck der Einflussnahme auf die Kontrolle erworben wurden; das Eigentum wird mit 5 % oder weniger angegeben.

Positive
  • Transparent disclosure showing 0 shares (0.0%) beneficial ownership by the reporting persons
  • Certification included that securities are held in the ordinary course and not to influence control
Negative
  • No voting or dispositive power reported by the filers — they hold 0 shares (0.0%)

Insights

TL;DR: Reporting parties disclose zero ownership and no voting or dispositive power; impact on equity holders is neutral.

The Schedule 13G/A shows 0 shares (0.0%) beneficially owned by Rosalind Advisors, Rosalind Master Fund, Steven Salamon and Gilad Aharon. All entries for sole and shared voting and dispositive power are zero and the filing indicates ownership of 5% or less. This is a routine disclosure from an adviser and portfolio managers; it confirms no equity stake or control intent from the named parties.

TL;DR: No reported stake and an explicit certification that holdings are not for control; no governance influence from these filers.

The document identifies the reporting parties and their roles and certifies that the securities are held in the ordinary course and not to change or influence control. With 0 shares (0.0%) and no voting/dispositive power recorded, there is no material governance impact from these entities or individuals based on this filing.

OptiNose, Inc. ha comunicato che Rosalind Advisors, Rosalind Master Fund L.P., Steven Salamon e Gilad Aharon dichiarano una partecipazione beneficiaria pari a 0 azioni ordinarie (0,0%) del capitale ordinario di OptiNose. La comunicazione non indica poteri di voto né poteri dispositivi, né in forma esclusiva né condivisa, per alcuno dei soggetti segnalanti.

Il documento individua Rosalind Advisors come consulente e Salamon e Aharon come gestori di portafoglio e contiene la certificazione che i titoli sono detenuti nell'ambito dell'ordinaria attività di gestione e non sono stati acquisiti al fine di influenzare il controllo; la partecipazione è riportata come pari al 5% o inferiore.

OptiNose, Inc. informa que Rosalind Advisors, Rosalind Master Fund L.P., Steven Salamon y Gilad Aharon declaran una propiedad beneficiaria de 0 acciones ordinarias (0,0%) del capital social ordinario de OptiNose. El informe no registra poder de voto ni poder dispositivo, ni en forma exclusiva ni compartida, para ninguno de los informantes.

La declaración identifica a Rosalind Advisors como asesor y a Salamon y Aharon como gestores de cartera e incluye la certificación de que los valores se mantienen en el curso ordinario del negocio y no se adquirieron para influir en el control; la participación se informa como del 5% o menos.

OptiNose, Inc.의 제출서류에 따르면 Rosalind Advisors, Rosalind Master Fund L.P., Steven Salamon 및 Gilad Aharon이 OptiNose 보통주를 0주(0.0%) 보유한 것으로 보고했습니다. 제출서류에는 어떤 보고인에 대해서도 단독 또는 공동의 의결권이나 처분권이 기재되어 있지 않습니다.

진술서는 Rosalind Advisors를 자문사로, Salamon과 Aharon을 포트폴리오 매니저로 명시하며, 증권이 통상적인 영업 과정에서 보유되고 있고 지배권 행사 목적을 위해 취득된 것이 아니라는 인증을 포함하고 있습니다. 보유 비율은 5% 이하로 보고되었습니다.

OptiNose, Inc. indique que Rosalind Advisors, Rosalind Master Fund L.P., Steven Salamon et Gilad Aharon déclarent une participation bénéficiaire de 0 actions ordinaires (0,0 %) des actions ordinaires d'OptiNose. La déclaration ne mentionne aucun pouvoir de vote ni aucun pouvoir de disposition, ni en propre ni partagé, pour aucun des déclarants.

Le document identifie Rosalind Advisors comme conseiller et Salamon et Aharon comme gestionnaires de portefeuille et inclut la certification que les titres sont détenus dans le cours normal des affaires et n'ont pas été acquis pour influencer le contrôle ; la participation est indiquée comme égale ou inférieure à 5 %.

OptiNose, Inc. legt offen, dass Rosalind Advisors, Rosalind Master Fund L.P., Steven Salamon und Gilad Aharon eine wirtschaftliche Beteiligung von 0 Stammaktien (0,0 %) an den Stammaktien von OptiNose melden. In der Meldung werden weder alleiniges noch gemeinsames Stimmrecht noch alleiniges oder gemeinsames Verfügungsrecht für eine der meldepflichtigen Personen angegeben.

Die Erklärung nennt Rosalind Advisors als Berater und Salamon sowie Aharon als Portfoliomanager und enthält die Bestätigung, dass die Wertpapiere im normalen Geschäftsverlauf gehalten werden und nicht zum Zweck der Einflussnahme auf die Kontrolle erworben wurden; das Eigentum wird mit 5 % oder weniger angegeben.






Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Rosalind Advisors, Inc.
Signature:Steven Salamon
Name/Title:President
Date:08/11/2025
SALAMON STEVEN A J
Signature:Steven Salamon
Name/Title:Steven Salamon
Date:08/11/2025
Aharon Gil
Signature:Gil Aharon
Name/Title:Gil Aharon
Date:08/11/2025
Rosalind Master Fund L.P.
Signature:Mike McDonald
Name/Title:Director, Rosalind (Cayman) Ltd. (as General Partner to Rosalind Master Fund)
Date:08/11/2025

FAQ

Who filed the Schedule 13G/A for OPTN?

Rosalind Advisors, Rosalind Master Fund L.P., Steven Salamon and Gilad Aharon are named as the reporting persons.

How many OptiNose (OPTN) common shares do the reporting persons beneficially own?

0 shares (0.0%).

Do the reporting persons have voting or dispositive power over OptiNose shares?

No. The filing reports zero sole and zero shared voting and dispositive power for each reporting person.

Does the filing indicate the reporting persons seek to influence control of OptiNose?

No. The filing includes a certification that the securities were not acquired and are not held for the purpose of changing or influencing control.

Is the ownership reported above or below the 5% threshold?

Below 5%. The filing indicates ownership of 5% or less.

What roles do Steven Salamon and Gilad Aharon have according to the filing?

They are identified as portfolio managers associated with Rosalind Advisors, the adviser to Rosalind Master Fund.
Optinose

NASDAQ:OPTN

OPTN Rankings

OPTN Latest News

OPTN Stock Data

96.41M
9.47M
7.17%
72.66%
2.42%
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United States
YARDLEY